Search Results - "Herrero, Fernando Rivera"

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial by Rha, Sun Young, Oh, Do-Youn, Yañez, Patricio, Bai, Yuxian, Ryu, Min-Hee, Lee, Jeeyun, Rivera, Fernando, Alves, Gustavo Vasconcelos, Garrido, Marcelo, Shiu, Kai-Keen, Fernández, Manuel González, Li, Jin, Lowery, Maeve A, Çil, Timuçin, Cruz, Felipe Melo, Qin, Shukui, Luo, Suxia, Pan, Hongming, Wainberg, Zev A, Yin, Lina, Bordia, Sonal, Bhagia, Pooja, Wyrwicz, Lucjan S

“…PD-1 inhibitors combined with chemotherapy have shown efficacy in gastric or gastro-esophageal junction cancer. We compared the efficacy and safety of…”
Get full text

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial by Wang-Gillam, Andrea, MD, Li, Chung-Pin, Prof, Bodoky, György, Prof, Dean, Andrew, MD, Shan, Yan-Shen, Prof, Jameson, Gayle, MSN, Macarulla, Teresa, MD, Lee, Kyung-Hun, MD, Cunningham, David, Prof, Blanc, Jean F, Prof, Hubner, Richard A, PhD, Chiu, Chang-Fang, Prof, Schwartsmann, Gilberto, MD, Siveke, Jens T, Prof, Braiteh, Fadi, MD, Moyo, Victor, MBBCh, Belanger, Bruce, PhD, Dhindsa, Navreet, DDS, Bayever, Eliel, MBBCh, Von Hoff, Daniel D, Prof, Chen, Li-Tzong, Prof

“…Summary Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated…”
Get full text

A meta-analysis of efficacy and safety data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in adult patients with RAS wild-type metastatic colorectal cancer by sidedness by Yoshino, Takayuki, Hooda, Naushin, Younan, Diana, Muro, Kei, Shitara, Kohei, Heinemann, Volker, O’neil, Bert Howard, Herrero, Fernando Rivera, Peeters, Marc, Soeda, Junpei, Suh, Mina, Reichert, Heidi, Mezzi, Khalid, Fryzek, Jon, Chia, Victoria, Rehn, Marko, Stintzing, Sebastian

“…The first-line treatment choice of EGFRIs plus doublet chemotherapy vs. bevacizumab plus doublet chemotherapy remains a topic of interest for patients with…”
Get full text

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study by Kawazoe, Akihito, Xu, Rui-Hua, García-Alfonso, Pilar, Passhak, Maria, Teng, Hao-Wei, Shergill, Ardaman, Gumus, Mahmut, Qvortrup, Camilla, Stintzing, Sebastian, Towns, Kathryn, Kim, Tae Won, Shiu, Kai Keen, Cundom, Juan, Ananda, Sumitra, Lebedinets, Andrey, Fu, Rong, Jain, Rishi, Adelberg, David, Heinemann, Volker, Yoshino, Takayuki, Elez, Elena

“…Treatment options are limited for patients with previously treated metastatic colorectal cancer (mCRC). In the LEAP-017 study, we evaluate whether lenvatinib…”
Get full text

A panel discussion of controversies and challenges in the adjuvant treatment of colon cancer by Díaz-Rubio García, Eduardo, Abad Esteve, Albert, Antón Torres, Antonio, Aranda Aguilar, Enrique, Benavides Orgaz, Manuel, Carrato Mena, Alfredo, Cervantes Ruipérez, Andrés, Feliu Batle, Jaime, García Alfonso, Pilar, García Foncillas, Jesús, Grávalos Castro, Cristina, Navarro García, Matilde, Rivera Herrero, Fernando, Tabernero Caturla, José María

“…Current issues of adjuvant therapy for colon cancer concern the introduction of drugs other than fluorouracil-5/leucovorin (5-FU/LV), the benefits for stage II…”
Get full text

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone by Paz-Ares, Luis, López-Pousa, Antonio, Poveda, Andrés, Balañá, Carmen, Ciruelos, Eva, Bellmunt, Joaquim, del Muro, Javier García, Provencio, Mariano, Casado, Antonio, Rivera-Herrero, Fernando, Izquierdo, Miguel Ángel, Nieto, Antonio, Tanović, Adnan, Cortes-Funes, Hernán, Buesa, José María

“…Summary Purpose This study assesses the efficacy, toxicity and pharmacokinetic profile of trabectedin with or without prophylactic dexamethasone co-treatment…”
Get full text

SEOM guidelines for the treatment of bone metastases from solid tumours by Cassinello Espinosa, Javier, González del Alba Baamonde, Aránzazu, Rivera Herrero, Fernando, Holgado Martín, Esther

“…Bone metastases are a common and distressing effect of cancer, being a major cause of morbidity in many patients with advanced stage cancer, in particular in…”
Get full text

SEOM clinical guidelines for treatment of prostate cancer by Arranz Arija, José Ángel, Cassinello Espinosa, Javier, Climent Durán, Miguel Ángel, Rivera Herrero, Fernando

“…Prostate cancer (PC) is the most common cancer in men. Many patients have prolonged survival and die of other diseases, so treatment decisions are often…”
Get full text

SEOM clinical guidelines for the adjuvant treatment of colorectal cancer by Grávalos Castro, Cristina, Maurel Santasusana, Joan, Rivera Herrero, Fernando, Salazar Soler, Ramón, Sevilla García, Isabel, Sastre Valera, Javier, Tabernero Caturla, José M., González Flores, Encarnación, Lomas Garrido, María, Isla Casado, Dolores

“…Colorectal cancer is the third most common malignant neoplasm and the second cause of death by cancer in western countries. In this manuscript, the clinical…”
Get full text